Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective.

Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective.
Acta Haematol. 2020 Jul 28;:1-14
Authors: Cheung CKM, Law MF, Lui GCY, Wong SH, Wong RSM
Abstract
Coronavirus disease 2019 (COVID-19) is affecting millions of patients worldwide. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family Coronaviridae, with 80% genomic similarities to SARS-CoV. Lymphopenia was commonly seen in infected patients and has a correlation to disease severity. Thrombocytopenia, coagulation abnormalities, and disseminated intravascular coagulation were observed in COVID-19 patients, especially those with critical illness and non-survivors. This pandemic has caused disruption in communities and hospital services, as well as straining blood product supply, affecting chemotherapy treatment and haematopoietic stem cell transplantation schedule. In this article, we review the haematological manifestations of the disease and its implication on the management of patients with haematological disorders.
PMID: 32721958 [PubMed - as supplied by publisher]

Source: Acta Haematologica - July 27, 2020 Category: Hematology Authors: Cheung CKM, Law MF, Lui GCY, Wong SH, Wong RSM Tags: Acta Haematol Source Type: research